Close Menu

NEW YORK (360Dx) – PerkinElmer reported after the close of the market on Thursday that total revenues for the first quarter of 2019 inched up a fraction of 1 percent year over year while revenues from its Diagnostics division grew 5 percent.

For the three months ended March 31, the Waltham, Massachusetts-based company posted revenues of $648.7 million, up from $644.0 million in Q1 2018. It beat analysts' average estimate of $645.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.